venBio Global Strategic Fund IV, L.P. — insider trades

Stock trades venBio Global Strategic Fund IV, L.P. reported on SEC Form 4 at ATTO Attovia Therapeutics, Inc..

• Aug 6, 2026: bought 382,352 shares of ATTO Attovia Therapeutics, Inc. ($6.50M)